Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Arcapta Quality-Of-Life Benefit For Higher Dose Isn't Enough Given Efficacy Data

Executive Summary

Novartis’ experience with its chronic obstructive pulmonary disease drug Arcapta Neohaler is a reminder that while quality-of-life data is nice to have, particularly from a competitive standpoint, it often plays merely a supporting role to clinical efficacy when it comes to product approval.
Advertisement

Related Content

Novartis Once-Daily COPD Combo Safe, Effective And Ready For Filing – Everywhere But In The U.S.
With LABA Safety Under Fire, Novartis Addresses Post-Market Studies
With LABA Safety Under Fire, Novartis Addresses Post-Market Studies
COPD Drug Dose Selection May Face Greater Scrutiny In Arcapta’s Wake
COPD Drug Dose Selection May Face Greater Scrutiny In Arcapta’s Wake
COPD Drug Dose Selection May Face Greater Scrutiny In Arcapta’s Wake
Arcapta Quality Of Life Data For High Dose Cannot Overcome Efficacy Questions

Topics

Advertisement
UsernamePublicRestriction

Register

PS053211

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel